ask="3.60"
ask_size="500"
average_daily_volume="235972"
bid="3.05"
bid_size="1000"
book_value="0.07"
change="-0.15"
change_from_200_day_moving_average="0.06"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-0.93"
change_From_52_week_low="0.75"
change_in_percent="-4.55%"
close="3.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.98"
ebitda="-30.33M"
eps_estimate_current_year="-1.04"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.71"
ex_dividend_date="N/A"
float_shares="26690000"
high="3.38"
high_52_weeks="4.08"
last_trade_date="3/7/2017"
last_trade_price="3.15"
last_trade_size="5995"
last_trade_time="4:00pm"
low="3.15"
low_52_weeks="2.40"
market_capitalization="142.80M"
moving_average_200_day="3.09"
moving_average_50_day="2.94"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.05%"
percent_change_from_50_day_moving_average="+7.09%"
percent_change_from_52_week_high="-22.79%"
percent_change_from_52_week_low="+31.25%"
previous_close="3.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="45.83"
price_per_sales="11.82"
revenue="12.65M"
shares_outstanding="45333000"
short_ratio="20.25"
stock_exchange="NGM"
symbol="ACRX"
volume="198957"
weeks_range_52="2.40 - 4.08"
